Trial Profile
Phase I randomized, double-blind, placebo-controlled single and multiple ascending oral dose studies of BMS-986120 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Apr 2016
Price :
$35
*
At a glance
- Drugs BMS 986120 (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 05 Apr 2016 New trial record
- 19 Feb 2016 Results presented at the 41st International Stroke Conference